Loading market dashboard
Tourmaline Bio, Inc.
TRMLHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Tourmaline Bio, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $59.94M | $59.94M - $59.94M | $0.00 | -$4.534 | 2 |
| Dec 2028 | $4.53M | $4.53M - $4.53M | $0.00 | -$5.154 | 1 |
| Dec 2027 | $16.67M | $16.67M - $16.67M | $0.00 | -$4.64 | 5 |
| Dec 2026 | $8.57M | $8.57M - $8.57M | $0.00 | -$4.036 | 5 |
| Dec 2025 | $8.57M | $8.57M - $8.57M | $0.00 | -$3.703 | 5 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.898 | 0 |
| Dec 2023 | $0.00 | $0.00 - $0.00 | $0.00 | -$3.70 | 0 |